3 ms·
Great news. I have not followed this, can you tell if it looks like this be any less susceptible resistance development?
by throwaway5752 7y ago
Great news. I have not followed this, can you tell if it looks like this be any less susceptible resistance development?
- classichasclass 7y agoCouldn't say definitively, but given that the biggest risks for resistance are monotherapy and intermittent therapy, shorter, less complex courses help to reduce the effective occurrence of both. Currently my MDR and XDR patients have about an 18+ month time frame; slashing the treatment time potentially to a third is a huge win, and we have robust directly-observed therapy infrastructure to ensure doses are actually taken. Unfortunately this last is not guaranteed in the developing world.